Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.

Geier DA, Kern JK, Geier MR.

J Toxicol Environ Health A. 2009;72(24):1585-91. doi: 10.1080/15287390903232475.

PMID:
20077233
2.

A prospective study of mercury toxicity biomarkers in autistic spectrum disorders.

Geier DA, Geier MR.

J Toxicol Environ Health A. 2007 Oct;70(20):1723-30.

PMID:
17885929
3.

A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.

Kern JK, Geier DA, Adams JB, Geier MR.

Biometals. 2010 Dec;23(6):1043-51. doi: 10.1007/s10534-010-9349-6. Epub 2010 Jun 9.

PMID:
20532957
4.

Biomarkers of environmental toxicity and susceptibility in autism.

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR.

J Neurol Sci. 2009 May 15;280(1-2):101-8. doi: 10.1016/j.jns.2008.08.021. Epub 2008 Sep 25.

PMID:
18817931
5.
6.

Porphyrinuria in Korean children with autism: correlation with oxidative stress.

Youn SI, Jin SH, Kim SH, Lim S.

J Toxicol Environ Health A. 2010;73(10):701-10. doi: 10.1080/15287391003614000.

PMID:
20391113
7.

Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins.

Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR.

Pediatr Int. 2011 Apr;53(2):147-53. doi: 10.1111/j.1442-200X.2010.03196.x.

PMID:
20626635
8.

Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.

Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R.

Toxicol Appl Pharmacol. 2006 Jul 15;214(2):99-108. Epub 2006 Jun 16.

PMID:
16782144
9.

Are urinary porphyrins a valid diagnostic biomarker of autism spectrum disorder?

Shandley K, Austin DW, Bhowmik JL.

Autism Res. 2014 Oct;7(5):535-42. doi: 10.1002/aur.1385. Epub 2014 Apr 22.

PMID:
24756868
10.

Hair toxic metal concentrations and autism spectrum disorder severity in young children.

Geier DA, Kern JK, King PG, Sykes LK, Geier MR.

Int J Environ Res Public Health. 2012 Dec 6;9(12):4486-97. doi: 10.3390/ijerph9124486.

11.

Modeling clinical outcome of children with autistic spectrum disorders.

Coplan J, Jawad AF.

Pediatrics. 2005 Jul;116(1):117-22.

PMID:
15995041
12.

Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders.

Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik-Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J.

Biol Trace Elem Res. 2015 Feb;163(1-2):2-10. doi: 10.1007/s12011-014-0121-6. Epub 2014 Sep 19.

PMID:
25234471
13.

Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Khaled EM, Meguid NA, Bjørklund G, Gouda A, Bahary MH, Hashish A, Sallam NM, Chirumbolo S, El-Bana MA.

Metab Brain Dis. 2016 Dec;31(6):1419-1426. Epub 2016 Jul 13.

PMID:
27406246
14.

A comparison of urinary mercury between children with autism spectrum disorders and control children.

Wright B, Pearce H, Allgar V, Miles J, Whitton C, Leon I, Jardine J, McCaffrey N, Smith R, Holbrook I, Lewis J, Goodall D, Alderson-Day B.

PLoS One. 2012;7(2):e29547. doi: 10.1371/journal.pone.0029547. Epub 2012 Feb 15.

15.

Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity.

Woods JS.

Can J Physiol Pharmacol. 1996 Feb;74(2):210-5.

PMID:
8723034
16.

A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children's dental amalgam trial.

Geier DA, Carmody T, Kern JK, King PG, Geier MR.

Biometals. 2011 Apr;24(2):215-24. doi: 10.1007/s10534-010-9387-0. Epub 2010 Nov 5.

PMID:
21053054
17.

Developing a schedule to identify social communication difficulties and autism spectrum disorder in young children with visual impairment.

Absoud M, Parr JR, Salt A, Dale N.

Dev Med Child Neurol. 2011 Mar;53(3):285-8. doi: 10.1111/j.1469-8749.2010.03846.x. Epub 2010 Dec 17.

18.

A review of candidate urinary biomarkers for autism spectrum disorder.

Wang L, Angley MT, Gerber JP, Sorich MJ.

Biomarkers. 2011 Nov;16(7):537-52. doi: 10.3109/1354750X.2011.598564. Review.

PMID:
22022826
19.
20.

Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).

Freesemann AG, Bhutani LK, Jacob K, Doss MO.

Arch Dermatol Res. 1997 Apr;289(5):272-6.

PMID:
9164637

Supplemental Content

Support Center